Design Therapeutics (DSGN) Other Non-Current Assets (2020 - 2025)
Design Therapeutics recorded quarterly Other Non-Current Assets of $427000.0 in Q1 2025, little changed quarter-over-quarter from $427000.0 in Q4 2024, and little changed year-over-year from $427000.0 in Q1 2024.
Design Therapeutics' Other Non-Current Assets history runs 5 years deep, the most recent figure standing at $427000.0 for Q1 2025.
- In Q1 2025, Other Non-Current Assets changed 0.0% year-over-year to $427000.0; the TTM figure through Mar 2025 stood at $427000.0 (changed 0.0% YoY), while the FY2024 annual figure was $427000.0, down 0.7% from the prior year.
- Other Non-Current Assets came in at $427000.0 for Q1 2025 at Design Therapeutics, roughly flat from $427000.0 in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $474000.0 in Q2 2022 to a low of $427000.0 in Q1 2024.
- A 4-year average of $441583.3 and a median of $433500.0 in 2023 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets retreated 6.33% in 2023 and changed 0.0% in 2025, its largest moves.
- Design Therapeutics' Other Non-Current Assets stood at $459000.0 in 2022, then decreased by 6.32% to $430000.0 in 2023, then dropped by 0.7% to $427000.0 in 2024, then changed by 0.0% to $427000.0 in 2025.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $427000.0, $427000.0, and $427000.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Design Therapeutics | 640.15 Mn | 417.32 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 427,000.00 |
| Dec 31, 2024 | 427,000.00 |
| Sep 30, 2024 | 427,000.00 |
| Jun 30, 2024 | 429,000.00 |
| Mar 31, 2024 | 427,000.00 |
| Dec 31, 2023 | 430,000.00 |
| Sep 30, 2023 | 437,000.00 |
| Jun 30, 2023 | 444,000.00 |
| Mar 31, 2023 | 452,000.00 |
| Dec 31, 2022 | 459,000.00 |
| Sep 30, 2022 | 466,000.00 |
| Jun 30, 2022 | 474,000.00 |
| Dec 31, 2020 | 212,000.00 |